Who
Ludwig Hantson
Director
Company insider
Files Form 4 as: Director, Ionis Pharmaceuticals; Director, Hologic; CEO, Alexion Pharmaceuticals; President and CEO, Baxalta; Corporate Vice President, Baxter International.
In numbers
- Trades disclosed
- 121
- Buys
- 1
- Sells
- 6
- Bought
- $1.2M
- Sold
- $7.0M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 7 May 2010
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,399 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,399 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,753 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,753 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HologicMedical Devices | SEC FORM 4 Code D | —16,146 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —2,012 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —6,523 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —2,012 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —6,523 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —7,322 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,055 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,293 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —4,210 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —4,536 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,535 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —7,322 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,055 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,293 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —4,210 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —4,536 | filing |
News
Baxter International (NYSE:BAX) Stock Picked Up by Analysts at BarclaysBAX · tickerreport.com · 9 Oct 2026Reviewing Omnicell (NASDAQ:OMCL) & Baxter International (NYSE:BAX)BAX · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Ludwig Hantson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.